Our novel finding of xCT-upregulation suggests caution must be employed when attempting to inhibit ferroptosis by restoring glutathione antioxidant capabilities via Xc--targeting, as this may contribute to further excitotoxicity and energy deficiency in AD. This evidence concerns the gene SLC7A11 and Alzheimer disease.